BioTrack Capital
Overview
BioTrack Capital is a venture capital firm established in 2017 that focuses on investing in and incubating outstanding early-stage biotech, medtech as well as healthcare cross disciplinary sectors (AI and digital healthcare, consumer healthcare etc) . The firm manages four funds and has total assets under management over USD1Bn . Since its inception, BioTrack distinguishes itself as the entrepreneur founded VC with extensive industry ecosystem . Its ecosystem consists of leading global biopahrma, medtech companies and other multinational healthcare conglomerates, which not only provide deep industry insights and value-add service but also empower its portfolio companies in going overseas and global expansion .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shanghai Carbonology Technology Co., Ltd. | Jun 2026 | Series A | Lead |
| Aureka | Apr 2026 | Series A Extension | Co-investor |
| Syneron Bio | Mar 2026 | Series B | Co-investor |
| Syneron Bio | Mar 2026 | Series B | Co-investor |
| Hangzhou Sneuro Medical Technology Co., Ltd. | Mar 2026 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
